Adamietz I A, Schemmann F, Baum R P, Knecht R, Saran F, Mose S, Thilmann C, Hör G, Böttcher H D
Abteilung für Strahlentherapie, Johann Wolfgang Goethe-Universität, Frankfurt am Main.
Strahlenther Onkol. 1995 May;171(5):278-83.
Introduction of monoclonal antibodies (immunoscintigraphy) has significantly extended the diagnostic spectrum of nuclear medicine in oncology. The detection rate of this new method in patients bearing squamous cell carcinoma of head and neck is better compared to computed tomography and magnetic resonance imaging. In a prospective study, we examined whether immunoscintigraphy in addition to other imaging procedures is able to provide additional diagnostic information for radiation treatment planning.
单克隆抗体（免疫闪烁造影）的引入显著拓宽了核医学在肿瘤学中的诊断范围。与计算机断层扫描和磁共振成像相比，这种新方法对头颈部鳞状细胞癌患者的检测率更高。在一项前瞻性研究中，我们研究了免疫闪烁造影联合其他成像检查能否为放射治疗计划提供更多的诊断信息。
